Slide 1: Investor Presentation
Investor Presentation October 2025 INNOVATORS IN MRI PATIENT CARE
Slide 2: Forward-Looking Statements
Forward -Looking Statements This presentation contains a financial outlook for the full year 2025 and other forward-looking statements (i.e., statements that are not historical facts). Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date th
Slide 3: We Are MRI Patient Care
We Are MRI PATIENT CARE Safety in MRI Non-Magnetic • Portable MRI IV Infusion Pump • Portable MRI Patient Monitor • MRI Room Entry Safety - FMD 3
Slide 4: Strong Revenue, Highly Profitable, Solid Growth
Strong Revenue Highly Profitable Solid Growth Robust Balance Sheet Return of Capital ~$73M in 2024 Gross margins (>75%) and Double-digit revenue growth $53M cash @ June 30, 2025, Delivering returns to our Guidance of $80M- operating margins (>25%) with no debt investors via a $.17 quarterly $82.5M i
Slide 5: Iradimed Timeline
Iradimed Timeline Susi and his Invivo team develop specialized The Iradimed 3870 Next- wireless Gen IV infusion pump is technology in slated for release to the MRI with the IRMD Initial Public market in late 2025. 3150 Omni-Trak Offering on Nasdaq 1987 1996 2005 2012 2014 2016 2025 Susi founds Iradi
Slide 6: MRI Environment Challenge
MRI Environment Challenge Why a special niche? Equipment Risks FDA Reported MRI Adverse Event Types1 • Ferrous components create hazards Unclear Acoustic • Device performance altered 4% by magnetic field Misc. 6% • Burn risk from conductive 6% materials (wire danger) Image Quality 6% • Image artifac
Slide 7: The Solution for MRI Workflow Challenge: MRI-Safe Devices in Critical Care
The Solution for MRI Workflow Challenge : MRI -Safe Devices in Critical Care Bedside Set-Up Transport MRI Exam Return Post MRI Connect the MRI-safe Lightweight MRI safe Non-magnetic MRI Seamless care during Back to bedside as monitor and IV pump devices enable smooth safe devices support patient tra
Slide 8: Our Foundational Product - iRadimed 3860+
Our Foundational Product - iRadimed 3860 + Non-Magnetic IV Infusion Pump System • No direct competition • Wireless remote display • Average mid -70% gross margins • Proprietary IV sets provide a recurring revenue component • Current global install base ~ 13,500 IV channels • Initial market assumptio
Slide 9: Upcoming Next-Gen IV Pump Launch
Upcoming Next - Gen IV Pump Launch Provides Large Revenue Opportunity MRIdium 3870 Key Features Market Opportunity Introduces an enhanced, intuitive graphical Significant replacement potential for the touchscreen user interface next-gen pump as a large portionof the existing installed base will
Slide 10: IRadimed 3880
IRadimed 3880 Non-Magnetic Patient Monitor • Only Portable and Non-magnetic MR monitor • Highly advanced “homegrown” piezo technology • Average mid -70% gross margins • Proprietary electrodes and disposables provide a recurring revenue component Product Opportunity/Growth • One direct competitor – I
Slide 11: Established Market with Significant Room to Grow
Established Market with Significant Room to Grow 3 Global Existing MRI Scanner Base Supported by Strong Fundamentals Current IRadimed Install Base All MRI Scanners ~38,000 MRI Scanners High Acuity ~13,500 Hospitals Pump Current IV Channels ~26,700 Install Base MRI Scanners Critical Care ~24,800 Mult
Slide 12: Technical Expertise and Intellectual Property
Technical Expertise and Intellectual Property • Breakthrough use of piezo ceramic Ultrasonic Motive technique • Non-magnetic and RF-quiet medical device design • MRI wireless connectivity – custom radio design • 20 issued patents and two pending patents 12
Slide 13: Commercial Strategy
Commercial Strategy • Continue expansion of MRI-focused U.S. direct sales force and our international sales efforts • 30 U.S. territories • 3 International sales personnel • 80+ countries with distribution channels • Provide best-in-class customer service and user experience – 10 U.S. field clinical
Slide 14: Proven Track Record of Growth and Profitability
Proven Track Record of Growth and Profitability 14
Slide 15: Iradimed Executive Team
Iradimed Executive Team Roger Susi Jack Glenn Jeff Chiprin PRESIDENT AND CHIEF CHIEF FINANCIAL CHIEF COMMERCIAL EXECUTIVE OFFICER OFFICER OFFICER 15
Slide 16: Iradimed Highlights
Iradimed Highlights 1 Upcoming Launch of Next-Gen Pump Will Further Catalyze Growth Disruptive Patient Monitoring Technology Platform that Addresses the 2 Challenges of MRI Workflow Uniquely Positioned to Capitalize on a Global Market Opportunity Across 3 Pumps and Monitors Highly Protected and Diff
Slide 17: Thank You
INNOVATORS IN MRI PATIENT CARE Thank You InvestorRelations@Iradimed.com